bendamustine hydrochloride has been researched along with Aplasia Pure Red Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Lin, X; Xu, Q; Yu, J; Zhang, K | 1 |
| Chonabayashi, K; Hanyu, Y; Kanda, J; Mizumoto, C; Shimazu, Y; Takaori-Kondo, A | 1 |
2 other study(ies) available for bendamustine hydrochloride and Aplasia Pure Red Cell
| Article | Year |
|---|---|
CB-LPD, MGUS, T-LGLL, and PRCA: A rare case report of 4 concomitant hematological disorders.
Topics: Aged; Anemia; Antineoplastic Agents; Bendamustine Hydrochloride; Bortezomib; Dexamethasone; Humans; Leukemia, Large Granular Lymphocytic; Lymphoproliferative Disorders; Male; Monoclonal Gammopathy of Undetermined Significance; Red-Cell Aplasia, Pure; Rituximab; Sirolimus | 2021 |
Successful treatment with cyclosporine of pure red cell aplasia induced by obinutuzumab bendamustine therapy.
Topics: Antibodies, Monoclonal, Humanized; Bendamustine Hydrochloride; Cyclosporine; Humans; Immunosuppressive Agents; Red-Cell Aplasia, Pure | 2023 |